EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved detection of central vein sign in multiple sclerosis using optimized susceptibility weighted imaging at 3 Tesla

Yin-Chen Hsu, Sreekanth Madhusoodhanan Nair, Lixia Wang, Michael Luu, Elaina Luskin, Diana Ayrapetyan, Angel Liu, Abdul Jaber Tayem, Nader Binesh, Marcel Maya, Yibin Xie, Debiao Li und 5 weitere

European Radiology · 18.11.2026

DOI: 10.1007/s00330-026-13069-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, online erschienen am 18.11.2026. Verfasst von Yin-Chen Hsu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The central vein sign (CVS) is a novel diagnostic imaging biomarker that improves differentiation of white matter lesions (WMLs) caused by multiple sclerosis (MS) and radiological mimics. While susceptibility-weighted imaging (SWI) is widely available for visualizing venous structures, standard SWI protocols are not optimized for standalone CVS detection and require T2-FLAIR images to co-localize T2-hyperintense WMLs. This study evaluated whether an optimized SWI protocol improves CVS detection and reader confidence at 3 T. Materials and methods Seventeen patients with a clinical diagnosis of MS were scanned on a 3 T MRI scanner using a standard SWI and an optimized SWI acquired with a lower flip angle (FA = 5°). Two radiologists, blinded to the SWI imaging protocols, evaluated the presence of CVS and their confidence levels. Subsequent subject-level analysis was performed to assess the positive detection rate for MS using the “Select-6” rule.

Results

Optimized SWI detected all CVS+ lesions identified by standard SWI plus 33 additional lesions (105 vs. 72). Optimized SWI detected more CVS+ lesions than standard SWI in 14/17 participants, with a higher median number of CVS+ lesions detected per participant (7.0 vs. 4.0; p < 0.001). Optimized SWI also increased high-confidence CVS+ classification compared with standard SWI ( p = 0.006). Positive detection rate for MS using Select-6 increased from 41.2% with standard SWI to 82.4% with optimized SWI ( p = 0.016).

Conclusion

This feasibility study demonstrates that acquiring SWI with a lower FA at 3 T significantly improves CVS detection, reader confidence, and positive detection rate for MS. Key Points Question Standard SWI can visualize venous structures at 3 T, but provides limited lesion conspicuity, which prevents standalone detection of the central vein sign (CVS) .

Findings

Optimized SWI with a low flip angle detects more CVS-positive lesions, increases high-confidence CVS classification, and improves MS detection rate using the Select-6 rule . Clinical relevance Optimized SWI improves CVS visibility and rater confidence without increasing scan time, providing a simple technical optimization for assessment of CVS at 3 T .

Schlagwörter

Stichwörter der Autor:innen

Central vein signMultiple sclerosisSusceptibility-weighted imaging

Autor:innen und Institutionen

  • Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Neuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Visual Outcomes Laboratory, Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Hsu, Y. C., Madhusoodhanan Nair, S., Wang, L., Luu, M., Luskin, E., Ayrapetyan, D., Liu, A., Tayem, A. J., Binesh, N., Maya, M., Xie, Y., Li, D., Kaisey, M., Sicotte, N. L., Al-Louzi, O., Ontaneda, D., & Sati, P. (2026). Improved detection of central vein sign in multiple sclerosis using optimized susceptibility weighted imaging at 3 Tesla. European Radiology. https://doi.org/10.1007/s00330-026-13069-3

Vancouver

Hsu YC, Madhusoodhanan Nair S, Wang L, Luu M, Luskin E, Ayrapetyan D, et al. Improved detection of central vein sign in multiple sclerosis using optimized susceptibility weighted imaging at 3 Tesla. European Radiology. 2026. doi:10.1007/s00330-026-13069-3

BibTeX
@article{Hsu2026,
  author = {Hsu, Yin-Chen and Madhusoodhanan Nair, Sreekanth and Wang, Lixia and Luu, Michael and Luskin, Elaina and Ayrapetyan, Diana and Liu, Angel and Tayem, Abdul Jaber and Binesh, Nader and Maya, Marcel and Xie, Yibin and Li, Debiao and Kaisey, Marwa and Sicotte, Nancy L and Al-Louzi, Omar and Ontaneda, Daniel and Sati, Pascal},
  title = {Improved detection of central vein sign in multiple sclerosis using optimized susceptibility weighted imaging at 3 Tesla},
  journal = {European Radiology},
  year = {2026},
  doi = {10.1007/s00330-026-13069-3}
}
Kostenlos starten →